ArticleTranslational lung cancer research2019

Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients?

Laura Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.